18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: A multicentre study

European Journal of Radiology, 11/14/2011

18F–FDG–PET/CT may have a potential role in asymptomatic patients with rising markers and negative conventional imaging. The findings agree with other studies in promoting regular investigations such as tumor markers and 18F–FDG–PET/CT rather than awaiting the developments of physical symptoms as suggested by current guidelines since the timely detection of early recurrence may have a major impact on therapy and survival.

Print Article Summary Cat 2 CME Report